Krystal Biotech Inc (KRYS)
158.41
-5.78
(-3.52%)
USD |
NASDAQ |
Apr 19, 16:00
161.65
+3.24
(+2.05%)
After-Hours: 20:00
Krystal Biotech Total Liabilities (Quarterly): 39.71M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 39.71M |
| September 30, 2023 | 34.40M |
| June 30, 2023 | 30.91M |
| March 31, 2023 | 42.28M |
| December 31, 2022 | 36.22M |
| September 30, 2022 | 35.61M |
| June 30, 2022 | 42.14M |
| March 31, 2022 | 68.32M |
| December 31, 2021 | 32.72M |
| September 30, 2021 | 42.86M |
| June 30, 2021 | 25.02M |
| March 31, 2021 | 12.37M |
| December 31, 2020 | 18.76M |
| September 30, 2020 | 9.731M |
| Date | Value |
|---|---|
| June 30, 2020 | 8.449M |
| March 31, 2020 | 6.762M |
| December 31, 2019 | 6.109M |
| September 30, 2019 | 6.586M |
| June 30, 2019 | 6.866M |
| March 31, 2019 | 6.218M |
| December 31, 2018 | 2.89M |
| September 30, 2018 | 2.161M |
| June 30, 2018 | 0.759M |
| March 31, 2018 | 0.452M |
| December 31, 2017 | 0.64M |
| September 30, 2017 | 2.475M |
| June 30, 2017 | 0.584M |
| December 31, 2016 | 1.893M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.109M
Minimum
Dec 2019
68.32M
Maximum
Mar 2022
26.62M
Average
30.91M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Axsome Therapeutics Inc | 397.26M |
| Alnylam Pharmaceuticals Inc | 4.051B |
| Catalyst Pharmaceuticals Inc | 82.23M |
| Ionis Pharmaceuticals Inc | 2.603B |
| Madrigal Pharmaceuticals Inc | 235.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 818.36M |
| Shareholders Equity (Quarterly) | 778.64M |
| Current Ratio | 17.76 |